We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Outcomes of Patients Who Undergo Aggressive Induction Therapy for Secondary Acute Myeloid Leukemia.
- Authors
Rizzieri, David A.; O'Brien, Jenny A.; Broadwater, Gloria; Decastro, Carlos M.; Dev, Prakash; Diehl, Louis; Beaven, Anne; Lagoo, Anand; Gockerman, Jon P.; Chao, Nelson J.; Moore, Joseph O.
- Abstract
The article presents a study that reviews survival of secondary acute myeloid leukemia (SAML) patients receiving aggressive induction chemotherapy. The study shows that the overall survival was 13.6 months and median event-free survival was eight months. It reveals that eight patients passed away shortly after receiving induction therapy due to side effects or the disease. It indicates that the median disease-free survival for patients attaining morphologic complete remission was nine months.
- Subjects
DRUG efficacy; DRUG therapy; HEALTH outcome assessment; CANCER chemotherapy; LEUKEMIA; CHRONIC myeloid leukemia; DISEASE remission; PATIENTS
- Publication
Cancer (0008543X), 2009, Vol 115, Issue 13, p2922
- ISSN
0008-543X
- Publication type
Article
- DOI
10.1002/cncr.24379